Thermo Fisher Scientific Inc
Key numbers
What the whole company is worth on the stock market.
Price ÷ last year's profit per share. Higher means investors pay more for each $1 of profit.
The same ratio using next year's expected profit.
How much the stock swings compared with the market: 1 moves like the market, 1.5 moves 50% more.
Yearly dividend as a share of the price.
What analysts say
27 analysts
Recent analyst actions
Financial health
Nine checks of profitability, debt and efficiency. 7–9 strong, 4–6 average, 0–3 weak.
A bankruptcy-risk score. Above 3 is the safe zone, 1.8–3 grey, below 1.8 distress.
Profitability and debt
Short-term assets ÷ short-term debts. Below 1 means more due within a year than on hand.
Fair value (DCF model)
A discounted-cash-flow model: what future cash flows are worth today. It is a model, not a promise.
Compared with similar companies
The company next to its sector peers.
| Company | Price | P/E | P/B | Market value |
|---|---|---|---|---|
| LLYEli Lilly and Company | 1,157.49 | 41.1 | 38.3 | $1.10T |
| JNJJohnson & Johnson | 254.78 | 29.1 | 6.1 | $612.91B |
| ABBVAbbVie Inc. | 266.69 | 74.4 | 94.4 | $469.63B |
| MRKMerck & Company, Inc. | 141.94 | 110.0 | 5.0 | $348.94B |
| UNHUnitedHealth Group Incorporated | 376.32 | 24.1 | 3.2 | $340.18B |
| TMOThermo Fisher Scientific Inc | 656.58 | 35.1 | 4.1 | $244.45B |
| AMGNAmgen Inc. | 402.60 | 24.9 | 20.4 | $217.86B |
| ABTAbbott Laboratories | 98.16 | 31.7 | 4.2 | $171.71B |
| PFEPfizer, Inc. | 27.50 | 36.3 | 1.6 | $157.11B |
| BMYBristol-Myers Squibb Company | 59.59 | 13.1 | 5.9 | $121.17B |
| Sector average | 42.0 | 18.3 |
About the company
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services internationally. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Biopharma Services. The Life Sciences Solutions segment includes reagents, instruments, and consumables for biological and medical research; discovery and production of drugs and vaccines; and diagnosis of infections and diseases. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The Specialty Diagnostics segment offers clinical diagnostics products, such as liquid ready-to-use and lyophilized i…
Data: Elcaro Core (Yahoo Finance, Binance, Treasury) · Information, not investment advice.